New drug IM-1617 enters first human tests for advanced cancers
Disease control
Not yet recruiting
This early-stage study tests a new drug called IM-1617 in about 175 people with advanced solid tumors that have spread or can't be removed by surgery. The goal is to find a safe dose and see if the drug can shrink tumors. The study has two parts: first, finding the right dose, th…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC